PCM
ALKS icon

Prelude Capital Management’s Alkermes ALKS Stock Holding History

Prelude Capital Management’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-35,500
Closed -$1.46M – 1707
2018
Q2 		$1.46M Buy
35,500
+7,800
+28% +$355K 0.09% 233
2018
Q1 		$1.6M Buy
27,700
+6,800
+33% +$398K 0.12% 168
2017
Q4 		$1.14M Buy
+20,900
New +$1.07M 0.09% 229
2017
Q3 		– Sell
-13,300
Closed -$771K – 1596
2017
Q2 		$771K Buy
13,300
+800
+6% +$46.5K 0.07% 252
2017
Q1 		$731K Buy
12,500
+1,900
+18% +$108K 0.07% 282
2016
Q4 		$589K Buy
+10,600
New +$567K 0.07% 293

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Prelude Capital Management's ALKS Position: Q2 2026 in Review

Prelude Capital Management sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 16,928 shares — an estimated $599K sold.

Prelude Capital Management first reported a position in ALKS in Q3 2013 and held it in 12 quarters. The position peaked at $652K in Q4 2015. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Prelude Capital Management reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 16,928 Alkermes shares in Q2 2026, an estimated $599K.
  • Prelude Capital Management first reported a position in Alkermes in Q3 2013 and held it in 12 quarters.
  • Prelude Capital Management's Alkermes position peaked at $652K in Q4 2015.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.